This trial studies a web-based cancer education tool called HOPE-Genomics. The tool provides patients with information about genomic testing and their own genomic test results. The goal is to improve patient's genomic knowledge and quality of patient-centered care.
- Ovarian Cancer
- Breast Cancer
- Prostate Cancer
- Pancreatic Cancer
- Lung Cancer
- Colorectal Cancer
1 Primary · 1 Secondary · Reporting Duration: Up to 12-month period after results disclosure
Awards & Highlights
3 Treatment Groups
Arm I (usual care)
1 of 3
Arm II (genomics test results, HOPE-Genomics)
1 of 3
Arm III (HOPE-Genomics, genomics test results)
1 of 3
435 Total Participants · 3 Treatment Groups
Primary Treatment: Educational Intervention · No Placebo Group · N/A
Who is running the clinical trial?
Age 18+ · All Participants · 1 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Frequently Asked Questions
How many participants are currently engaged in this research?
"Affirmative, the information posted on clinicaltrials.gov shows that this experiment is actively enrolling participants as of now. It was first uploaded December 30th 2021 and last revised February 11th 2022 to seek 435 subjects from 1 site." - Anonymous Online Contributor
Are there any available openings for participation in this trial?
"Affirmative, the information provided on clinicaltrials.gov denotes that this trial is actively enlisting patients as of now. The study was first published on December 30th 2021 and updated recently on February 11th 2022, with a target enrollment goal of 435 subjects from 1 site." - Anonymous Online Contributor